References
- Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348(16):1546–1554.
- Gaieski DF, Edwards JM, Kallan MJ, et al. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41(5):1167–1174.
- Suarez De La Rica A, Gilsanz F, Maseda E. Epidemiologic trends of sepsis in western countries. Ann Transl Med. 2016;4(17):325.
- Vincent J-L, Lefrant J-Y, Kotfis K, et al. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP). Intensive Care Med. 2018;44(3):337–344.
- Vincent J-L, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–353.
- Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: international Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304–377.
- Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–1755.
- Liu VX, Fielding-Singh V, Greene JD, et al. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am J Respir Crit Care Med. 2017;196(7):856–863.
- Moeloek NF Keputusan menteri kesehatan republik indonesia nomor hk.01.07/menkes/342/2017 tentang pedoman nasional pelayanan kedokteran tata laksana sepsis. 2017.
- Twycross A, Shorten A. Service evaluation, audit and research: what is the difference? Evid Based Nurs. 2014;17(3):65.
- Paul M, Shani V, Muchtar E, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54(11):4851–4863.
- Vernet G, Mary C, Altmann DM, et al. Surveillance for Antimicrobial Drug Resistance in Under-Resourced Countries. Emerg Infect Dis. 2014;20(3):434–441.
- Parathon H, Kuntaman K, Widiastoety TH, et al. Progress towards antimicrobial resistance containment and control in Indonesia. BMJ. 2017;358(Suppl1):31–35.
- Sugianli AK, Ginting F, Kusumawati RL, et al. Antimicrobial resistance in uropathogens and appropriateness of empirical treatment: a population-based surveillance study in Indonesia. J Antimicrob Chemother. 2017;72(5):1469–1477.
- Ginting F, Sugianli AK, Bijl G, et al. Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling. Am J Epidemiol. 2019;188(4):734–742.
- Puspitasari HP, Faturrohmah A, Hermansyah A. Do Indonesian community pharmacy workers respond to antibiotics requests appropriately? Trop Med Int Health. 2011;16(7):840–846.
- Avdic E, Carroll KC. The role of the microbiology laboratory in antimicrobial stewardship programs. Infect Dis Clin North Am. 2014;28(2):215–235.
- Nand P, Wilson MD, Cohen SH, et al. Curbing antimicrobial resistance: do physicians receive adequate education about antibiograms? J Infect. 2016;72(1):127–129.
- De Waele JJ, Dhaese S. Antibiotic stewardship in sepsis management: toward a balanced use of antibiotics for the severely ill patient. Expert Rev Anti Infect Ther. 2019;17(2):89–97.